CSM
CAMG Solamere Management Portfolio holdings
AUM
$122M
This Quarter Return
-1.24%
1 Year Return
+33.76%
3 Year Return
+51.78%
5 Year Return
+95.75%
10 Year Return
–
AUM
$220M
AUM Growth
+$220M
(-2.3%)
Cap. Flow
-$3.36M
Cap. Flow
% of AUM
-1.53%
Top 10 Holdings %
Top 10 Hldgs %
24.87%
Holding
146
New
11
Increased
46
Reduced
56
Closed
8
Top Buys
| 1 |
GSK
GSK
|
$4.24M |
| 2 |
MetLife
MET
|
$3.41M |
| 3 |
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
|
$2.75M |
| 4 |
PPL Corp
PPL
|
$2.68M |
| 5 |
AT&T
T
|
$1.59M |
Top Sells
| 1 |
Lear
LEA
|
$3.94M |
| 2 |
iShares Intermediate Government/Credit Bond ETF
GVI
|
$3.72M |
| 3 |
Ovintiv
OVV
|
$2.71M |
| 4 |
Darden Restaurants
DRI
|
$2.71M |
| 5 |
Intel
INTC
|
$2.06M |
Sector Composition
| 1 | Financials | 17.56% |
| 2 | Technology | 12.75% |
| 3 | Healthcare | 8.87% |
| 4 | Energy | 6.94% |
| 5 | Consumer Discretionary | 5.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
iShares Core US Aggregate Bond ETF
AGG
$131B
| $851K | 0.39% |
7,924
| – | – |
|
77
Bristol-Myers Squibb
BMY
$96B
| $843K | 0.38% |
13,347
-2,108
| -14% | -$133K |
|
78
S&P Global
SPGI
$167B
| $841K | 0.38% |
4,381
-226
| -5% | -$43.4K |
|
79
Globe Life
GL
$11.3B
| $829K | 0.38% |
9,849
-193
| -2% | -$16.2K |
|
80
Vanguard Short-Term Bond ETF
BSV
$38.5B
| $812K | 0.37% |
10,360
| – | – |
|
81
Vanguard Total Bond Market
BND
$134B
| $765K | 0.35% |
9,541
| – | – |
|
82
Toronto Dominion Bank
TD
$128B
| $716K | 0.33% |
12,614
+166
| +1% | +$9.42K |
|
83
iShares MSCI Emerging Markets ETF
EEM
$19B
| $694K | 0.32% |
14,384
+407
| +3% | +$19.6K |
|
84
Fastenal
FAST
$57B
| $675K | 0.31% |
12,407
-122
| -1% | -$6.64K |
|
85
Vanguard Mid-Cap Value ETF
VOE
$18.8B
| $674K | 0.31% |
+6,193
| New | +$674K |
|
86
Procter & Gamble
PG
$368B
| $659K | 0.3% |
8,295
| – | – |
|
87
CVS Health
CVS
$92.8B
| $647K | 0.29% |
10,465
-654
| -6% | -$40.4K |
|
88
Phillips 66
PSX
$54B
| $632K | 0.29% |
6,524
-914
| -12% | -$88.5K |
|
89
Novartis
NVS
$245B
| $614K | 0.28% |
7,651
+90
| +1% | +$7.22K |
|
90
Duke Energy
DUK
$95.3B
| $590K | 0.27% |
7,590
-504
| -6% | -$39.2K |
|
91
Southern Company
SO
$102B
| $590K | 0.27% |
13,304
-1,718
| -11% | -$76.2K |
|
92
Rayonier
RYN
$4.05B
| $539K | 0.25% |
15,360
-1,168
| -7% | -$41K |
|
93
Gen Digital
GEN
$18.6B
| $537K | 0.24% |
20,805
-250
| -1% | -$6.45K |
|
94
Bank of New York Mellon
BK
$74.5B
| $529K | 0.24% |
10,318
-250
| -2% | -$12.8K |
|
95
Berkshire Hathaway Class B
BRK.B
$1.09T
| $521K | 0.24% |
2,609
+60
| +2% | +$12K |
|
|
RDS.A
96
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $514K | 0.23% |
8,122
-685
| -8% | -$43.4K |
|
97
iShares S&P Small-Cap 600 Value ETF
IJS
$6.59B
| $511K | 0.23% |
3,387
+754
| +29% | +$114K |
|
98
AbbVie
ABBV
$372B
| $491K | 0.22% |
5,180
+119
| +2% | +$11.3K |
|
99
Brown-Forman Class B
BF.B
$14.2B
| $455K | 0.21% |
8,434
+3,325
| +65% | +$179K |
|
100
Oracle
ORCL
$635B
| $449K | 0.2% |
9,834
-1,697
| -15% | -$77.5K |
|